Atropine Completed Phase 4 Trials for Alzheimer's Disease (AD) / Delirium, Dementia, Amnestic, Cognitive Disorders / Mild Cognitive Impairment (MCI) Prevention

Indications	Status	Purpose	Phase
DBCOND0049114 (Alzheimer's Disease (AD)) DBCOND0032726 (Delirium, Dementia, Amnestic, Cognitive Disorders) DBCOND0038137 (Mild Cognitive Impairment (MCI))	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT01951118	Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly	Atropine (DB00572) Donepezil (DB00843)